ViewMind Inc. is a software development company specializing in precision measurement of neurocognitive health using ocular digital phenotyping. Their technology leverages context-aware artificial intelligence and digital brain assessments to deliver highly sensitive and specific insights into neurological health, supporting advancements in neurological drug development and precision care.
How does ViewMind Inc. help measure neurocognitive health?
ViewMind’s platform utilizes eye-tracking and digital phenotyping techniques to assess cognitive function and brain health. By analyzing ocular data with AI-driven algorithms, the company can detect subtle neurological changes with high accuracy. This approach is designed to assist clinicians, researchers, and pharmaceutical companies in early detection, monitoring, and validation of neurodegenerative disorders such as Alzheimer’s disease.
What makes ViewMind Inc. unique?
The company stands out for its combination of high sensitivity and specificity in neurocognitive measurement, delivered through digital assessments and context-aware AI. This enables more precise monitoring and diagnosis compared to traditional cognitive testing, making their solutions valuable for both clinical trials and individualized patient care.
Who uses ViewMind Inc.'s solutions?
ViewMind primarily serves organizations involved in neurological drug development, clinical research, and precision healthcare. This includes pharmaceutical companies, medical research institutions, and healthcare providers focused on neurodegenerative diseases and cognitive health monitoring. While specific customer names are not publicly listed, their target market is the B2B healthcare and life sciences sector.
How was ViewMind Inc. started and who leads the company?
ViewMind was founded by a multidisciplinary team with deep expertise in healthcare, neuroscience, artificial intelligence, and business leadership. Key team members include:
- Mark Edwards (CEO), a serial entrepreneur and experienced leader in both private and public companies
- Danilo Verge, MD MBA, a pharmaceutical executive with over 20 years in global medical roles
- Ariel Arelovich, PhD, a software development leader and eye-tracking specialist
- Gerardo Fernandez, PhD, a researcher in eye movement, neuroscience, and AI
- Francisco Lopera, MD, an authority on Alzheimer’s and neurodegenerative disorders
- Walter Greenleaf, PhD, a Stanford neuroscientist and VR healthcare expert
The founding team brings together decades of expertise across neurology, digital health, venture capital, and biotechnology, driving innovation at the intersection of AI, neuroscience, and digital diagnostics. For more information, visit their About page.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like ViewMind Inc. and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.